New Castle, DE, United States of America

Arthur John Elliott


Average Co-Inventor Count = 1.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • New Castle, DE (US) (1977)
  • Cedar Grove, NJ (US) (1979)
  • Sonoita, AZ (US) (2003)

Company Filing History:


Years Active: 1977-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Arthur John Elliott: Innovator in Pharmaceutical Chemistry

Introduction

Arthur John Elliott is a notable inventor based in New Castle, DE (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work primarily focuses on the development of innovative processes for the preparation of various chemical compounds.

Latest Patents

Elliott's latest patents include a groundbreaking method for the preparation of isoflurane. This process involves the reaction of 2,2,2-trifluoroethyl difluoro-methyl ether and chlorine in the presence of added water, conducted at low temperatures and/or at higher conversions. Another significant patent pertains to quinazolinone oxides, specifically 1-methyl-6-substituted-4-phenyl-quinazolin-2-one-3-oxides. These compounds serve as intermediates in the preparation of 3-fluorobenzodiazepines, which are valuable as tranquilizers, muscle relaxants, and sedatives.

Career Highlights

Throughout his career, Elliott has worked with prominent companies, including E.I. du Pont de Nemours and Company. His expertise in chemical processes has led to advancements in pharmaceutical applications, showcasing his innovative spirit and dedication to the field.

Collaborations

Elliott has collaborated with notable colleagues such as William J. O'Donnell and Paul Mazzell, Jr. These partnerships have contributed to the successful development of his patented processes and have enhanced the impact of his work in the industry.

Conclusion

Arthur John Elliott is a distinguished inventor whose contributions to pharmaceutical chemistry have paved the way for new advancements in the field. His innovative patents and collaborations reflect his commitment to improving chemical processes and developing valuable pharmaceutical intermediates.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…